Companion Animals

Cat HCM Screening: Protecting Breeding Cat Welfare

Echocardiographic screening for hypertrophic cardiomyopathy in breeding cats enables selection away from affected individuals, reducing the prevalence of this common and often fatal cardiac disease.

Key Facts

Welfare Considerations

HCM screening in breeding cats is one of the most direct welfare interventions available in pedigree cat health management. Breeding from affected individuals knowingly perpetuates a disease that causes cardiac deaths, aortic thromboembolism, and chronic cardiac compromise in offspring. The availability of DNA tests for the MYBPC3 mutation in Maine Coons means the genetic cause can be identified before phenotypic disease develops. Breed communities that embrace systematic screening reduce suffering across generations of affected cats. The welfare case for mandatory screening as a breeding prerequisite in predisposed breeds is compelling.

What You Can Do